PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine

BACKGROUND: Trivalent inactivated flu vaccines (TIV) are currently the best means to prevent influenza infections. However, the protection provided by TIV is partial (about 50%) and it is needed to improve the efficacy of protection. Since the respiratory tract is the main site of influenza replicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rioux, Gervais, Mathieu, Claudia, Russell, Alexis, Bolduc, Marilène, Laliberté-Gagné, Marie-Eve, Savard, Pierre, Leclerc, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022981/
https://www.ncbi.nlm.nih.gov/pubmed/24885884
http://dx.doi.org/10.1186/1477-3155-12-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022981/
https://www.ncbi.nlm.nih.gov/pubmed/24885884
http://dx.doi.org/10.1186/1477-3155-12-19

Ejemplares similares